MUC16 and ovarian carcinoma: Cancer antigen-125 (CA-125) is a macromolecular soluble protein, usually produced by luminal endothelial cells (e.g., pleura, peritoneum, and pericardium), and is a biomarker for monitoring the efficacy of ovarian cancer treatment [9].